However, in a rat model of non‐alcoholic fatty liver disease, serum AST and ALT levels in the HFD group with lycopene supplementation significantly decreased blood levels (Dietrich et al. 2016). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.